Heart

Aus coViki
(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
K
 
(23 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt)
Zeile 1: Zeile 1:
 
{{pnc}}
 
{{pnc}}
 +
{{ft|D}}
 +
*'''[[Myocardial injury complex]]'''
 +
*'''[[Myocardial infarction]]'''
 +
*'''[[Takotsubo-like]]'''
 +
*'''[[Myocarditis]]'''
 +
*'''[[RSP - On RAS drugs]]''' &hypertension
 +
*'''[[Heart rhythm disorders]]'''
 +
*'''[[Cardiogenic shock]]'''
 +
 +
*'''[[Air leak]]''' ''bullae, pneumothorax, -mediastinum...''
 +
{{tp|p=32443345|t=2020. SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report.|pdf=|usr=007}}
 +
 +
 +
 +
 +
'''to be sorted'''
 +
{{tp|p=32348058|t=2020. Les complications cardiaques de la maladie COVID-19 sont-elles associees a une mortalite plus elevee ?|pdf=|usr=007}}
 +
{{tp|p=32484975|t=2020. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.|pdf=|usr=007}}
 +
{{tp|p=32504747|t=2020. Cardiovascular complications in COVID-19: A systematic review and meta-analysis.|pdf=|usr=007}}
 +
{{tp|p=32395943|t=2020. Pericarditis aguda secundaria a COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32433342|t=2020. Cardiovascular Manifestation and Treatment in COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32453074|t=2020. Atrial Fibrillation in COVID-19: From epidemiological association to pharmacological implications.|pdf=|usr=007}}
 +
{{tp|p=32427645|t=2020. Pediatric Life-Threatening Coronavirus Disease 2019 With Myocarditis.|pdf=|usr=007}}
 +
{{tp|p=32433225|t=2020. Acute Inflammation and Elevated Cardiac Markers in a Two-Month-Old Infant with Severe Acute Respiratory Syndrome Coronavirus 2 Infection Presenting with Cardiac Symptoms.|pdf=|usr=007}}
 +
{{tp|p=32502128|t=2020. COVID-19-Associated Myocarditis in an Adolescent.|pdf=|usr=007}}
 +
{{tp|p=32512122|t=2020. Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.|pdf=|usr=007}}
 +
{{tp|p=32397558|t=2020. Impact of COVID-19 on the Cardiovascular System: A Review.|pdf=|usr=007}}
 +
{{tp|p=32393136|t=2020. COVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far?|pdf=|usr=007}}
 +
{{tp|p=32310612|t=2020. Cardiac Manifestations Of Coronavirus (COVID-19)|pdf=|usr=007}}
 +
{{tp|p=32360242|t=2020. COVID-19 Illness and Heart Failure: A Missing Link?|pdf=|usr=}}
 
{{tp|p=32310612|t=2020. Cardiac Manifestations Of Coronavirus (COVID-19)|pdf=|usr=}}
 
{{tp|p=32310612|t=2020. Cardiac Manifestations Of Coronavirus (COVID-19)|pdf=|usr=}}
{{tp|p=32281055|t=ä. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19 |pdf=|usr=}}
 
{{tp|p=32360119|t=ä. COVID-19 myopericarditis: It should be kept in mind in today s conditions |pdf=|usr=}}
 
 
{{tp|p=32317203|t=ä. Cardiovascular complications in COVID-19 |pdf=|usr=}}
 
{{tp|p=32317203|t=ä. Cardiovascular complications in COVID-19 |pdf=|usr=}}
{{tp|p=32251498|t=ä. Hypertension and COVID-19 |pdf=|usr=}}
 
{{tp|p=32209811|t=2020. Angiotensin II for the Treatment of COVID-19?Related Vasodilatory Shock |pdf=|usr=}}
 
 
{{tp|p=32303363|t=ä. ...impact sur le systeme cardiovasculaire...  |pdf=|usr=}}
 
{{tp|p=32303363|t=ä. ...impact sur le systeme cardiovasculaire...  |pdf=|usr=}}
{{tp|p=32344395|t=2020. The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection |pdf=|usr=}}
 
 
{{tp|p=32252591|t=2020. COVID-19 and the Heart |pdf=|usr=}}
 
{{tp|p=32252591|t=2020. COVID-19 and the Heart |pdf=|usr=}}
{{tp|p=32363334|t=ä. Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) |pdf=|usr=}}
 
 
{{tp|p=32371557|t=2020. SARS-CoV-2 and myocardial injury: Few answers, many questions |pdf=|usr=}}
 
 
{{tp|p=32331780|t=ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging |pdf=|usr=}}
 
{{tp|p=32331780|t=ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging |pdf=|usr=}}
 
{{tp|p=32318865|t=2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response |pdf=|usr=}}
 
{{tp|p=32318865|t=2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response |pdf=|usr=}}
 
{{tp|p=32247212|t=2020. Cardiovascular disease and COVID-19 |pdf=|usr=}}
 
{{tp|p=32247212|t=2020. Cardiovascular disease and COVID-19 |pdf=|usr=}}
 +
{{tp|p=32354800|t=2020. Cardiovascular manifestations and treatment considerations in covid-19 |pdf=|usr=}}
 +
{{tp|p=32305329|t=2020. Cardiovascular and Logistic Issues Associated With COVID-19 Pandemic |pdf=|usr=}}
 +
{{tp|p=32373465|t=ä. Syncope as the presenting symptom of COVID-19 infection |pdf=|usr=}}
 +
{{tp|p=32315757|t=ä. Current data on the cardiovascular effects of the COVID-19 |pdf=|usr=}}
 +
{{tp|p=32355222|t=ä. A novel COVID-19 and its effects on cardiovascular disease |pdf=|usr=}}
 +
{{tp|p=32360773|t=ä. May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?|pdf=|usr=}}
 +
{{tp|p=32276773|t=ä. Commentary: What is the relationship between Covid-19 and cardiovascular disease?|pdf=|usr=}}
 +
{{tp|p=32339565|t=ä. COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know |pdf=|usr=}}
 +
{{tp|p=32289321|t=ä. Cardiovascular molecular mechanisms of disease with COVID-19 |pdf=|usr=}}
 +
{{tp|p=C7151324|t=ä. The Heart in COVID19: Primary Target or Secondary Bystander?|pdf=|usr=}}
 +
{{tp|p=32360242|t=2020. COVID-19 Illness and Heart Failure: A Missing Link?|pdf=|usr=}}
 +
{{tp|p=32319272|t=2020. COVID-19 and cardiovascular disorder |pdf=|usr=}}
 +
{{tp|p=32340429|t=2020. The role of natriuretic peptide estimation in severe COVID-19 |pdf=|usr=}}
 +
{{tp|p=32293449|t=2020. Prognostic value of NT-proBNP in patients with severe COVID-19 |pdf=|usr=}}
 +
{{tp|p=32139904|t=ä. COVID-19 and the cardiovascular system |pdf=|usr=}}
 +
{{tp|p=32353374|t=ä. Towards precision management of cardiovascular patients with COVID-19 to reduce mortality |pdf=|usr=}}
 +
{{tp|p=32372844|t=ä. COVID-19 y tratamiento guiado con tests de diagnostico bioquemicos y moleculares  para reducir el dao cardiaco y la cardiotoxicidad |pdf=|usr=}}
 +
{{tp|p=32355394|t=ä. COVID-19 y shock cardiogonico: diferentes formas de presentacion cardiovascular con alta mortalidad |pdf=|usr=}}
 +
{{tp|p=32267110|t=2020. COVID-19 et maladies cardiovasculaires |pdf=|usr=}}
 +
{{tp|p=32227794|t=2020. At the  heart  of the COVID-19 outbreak: early cardiac implications and mitigating strategies |pdf=|usr=}}
 +
{{tp|p=32312365|t=2020.  Research advances in cardiovascular system damage caused by SARS-CoV-2 in children  |pdf=|usr=}}
 +
{{tp|p=32243205|t=2020. The Variety of Cardiovascular Presentations of COVID-19 |pdf=|usr=}}
 +
{{ttp|p=32354733|t=2020. SARS-CoV-2 pandemic and the cardiovascular system: What the non-cardiologist needs to know |pdf=|usr=}}
 +
{{tp|p=32282502|t=ä. Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019  (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32306491|t=2020. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review |pdf=|usr=}}
 +
{{tp|p=32270559|t=2020. Cardiac and arrhythmic complications in patients with COVID-19 |pdf=|usr=}}
 +
{{tp|p=32219357|t=2020. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32219363|t=2020. Potential Effects of Coronaviruses on the Cardiovascular System: A Review |pdf=|usr=}}
 +
{{tp|p=32356626|t=ä. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 |pdf=|usr=}}
 +
{{tp|p=32118392|t=2020.  Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations  |pdf=|usr=}}
 +
{{tp|p=32347088|t=2020.  Effects of novel coronavirus therapeutic drugs on cardiovascular system  |pdf=|usr=}}
 +
{{tp|p=C7196397|t=ä. A review of cardiac manifestations and predictors of outcome in patients with COVID ? 19 |pdf=|usr=}}
 +
{{tp|p=32423554|t=2020. Coronavirus disease 2019 and the cardiovascular system: Impacts and implications |pdf=|usr=}}
 +
{{tp|p=32451271|t=ä. Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications |pdf=|usr=}}
 +
{{tp|p=32349897|t=2020. Cardiovascular Consequences and Considerations of Coronavirus Infection ? Perspectives for the Cardiothoracic Anesthesiologist and Intensivist During the Coronavirus Crisis |pdf=|usr=}}
 +
{{tp|p=32297133|t=ä. Toward understanding the 2019 Coronavirus and its impact on the heart |pdf=|usr=}}
 +
{{tp|p=32292848|t=2020. COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies |pdf=|usr=}}
 +
{{tp|p=32292847|t=2020. The Heart in COVID-19: Primary Target or Secondary Bystander?|pdf=|usr=}}
 +
{{tp|p=C7195441|t=ä. Prognostic Value of Right Ventricular Longitudinal Strain in Patients with COVID-19 |pdf=|usr=}}
 +
{{tp|p=32456948|t=ä. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19 |pdf=|usr=}}
 +
{{tp|p=32423664|t=ä. A close-up on COVID-19 and cardiovascular diseases |pdf=|usr=}}
 +
{{tp|p=32368756|t=ä. HEART BRAKE-An unusual cardiac manifestation of Coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32129583|t=2020.  Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics  |pdf=|usr=}}
 +
{{tp|p=32409440|t=2020. The role of cardiac imaging in hospitalized COVID-19-positive patients.|pdf=|usr=007}}
 +
{{tp|p=32505331|t=2020. COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment?|pdf=|usr=007}}
 +
{{tp|p=32467423|t=2020. Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32499236|t=2020. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?|pdf=|usr=007}}
 +
{{tp|p=32425184|t=2020. Sindrome Takotsubo in corso di polmonite da SARS-CoV-2: una possibile complicanza cardiovascolare.|pdf=|usr=007}}
 +
{{tp|p=32282026|t=2020. Call to action for the cardiovascular side of COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32464652|t=2020. Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?|pdf=|usr=007}}
 +
{{tp|p=32464641|t=2020. Does epicardial fat contribute to COVID-19 myocardial inflammation?|pdf=|usr=007}}
 +
{{tp|p=32459851|t=2020. Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid the COVID-19 pandemic fight.|pdf=|usr=007}}
 +
{{tp|p=32469253|t=2020. The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) - a Systematic Echocardiographic Study.|pdf=|usr=007}}
 +
{{tp|p=32430971|t=2020. SARS-CoV2-related myocarditis-like syndroms: Shakespeare s question: What s in a name?|pdf=|usr=007}}
 +
{{tp|p=32462177|t=2020. Myocarditis detected after COVID-19 recovery.|pdf=|usr=007}}
 +
{{tp|p=32498096|t=2020. Intramural Hematoma as Unexpected Complication of COVID-19 Infection.|pdf=|usr=007}}
 +
{{tp|p=32464642|t=2020. Myocardial injury in severe COVID-19 infection.|pdf=|usr=007}}
 +
{{tp|p=32507570|t=2020. Acute myocarditis associated with COVID-19 infection.|pdf=|usr=007}}
 +
{{tp|p=32397816|t=2020. Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging.|pdf=|usr=007}}
 +
{{ttp|p=32492436|t=2020. Covid-19 may be exacerbated by right-to-left interatrial shunt.|pdf=|usr=007}}
 +
{{tp|p=32427416|t=2020. COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.|pdf=|usr=007}}
 +
{{tp|p=32410761|t=2020. Cardiac Valves: Another "Disaster-Hit Area" of COVID-19 Patients?|pdf=|usr=008}}
 +
{{tp|p=32434385|t=2020. Cardiac Arrhythmias in COVID-19 Infection.|pdf=|usr=007}}
 +
{{tp|p=32405457|t=2020. Cardiac injury, Arrhythmia and Sudden death in a COVID-19 patient.|pdf=|usr=008}}
 +
{{tp|p=32449420|t=2020. Interpretation of arrhythmogenic effects of COVID-19 disease through ECG.|pdf=|usr=007}}
 +
{{tp|p=32494800|t=2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.|pdf=|usr=007}}
 +
{{tp|p=32490506|t=2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.|pdf=|usr=007}}
 +
{{tp|p=32473085|t=2020. SARS-COV-2 infection presenting as ST-elevationmyocardial infarction.|pdf=|usr=007}}
 +
{{tp|p=32473051|t=2020. Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.|pdf=|usr=007}}
 +
{{tp|p=32514586|t=2020. Myokarditis in der Ara von SARS-CoV-2: ein einzelnes Teilchen eines komplexen Puzzles?|pdf=|usr=008}}
 +
{{tp|p=32522617|t=2020. Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement.|pdf=|usr=008}}
 +
{{tp|p=32534109|t=2020. Involvement of Cardiovascular System As The Critical Point in Coronavirus Disease 2019 (COVID-19) Prognosis and Recovery.|pdf=|usr=008}}
 +
{{tp|p=32407771|t=2020. Acute Myocardial Injury at Hospital Admission is Associated with All-cause Mortality in COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32449121|t=2020. Detailed hemodynamics of fulminant myocarditis caused by COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32395425|t=2020. Spontaneous pneumomediastinum occurring in the SARS-COV-2 infection.|pdf=|usr=008}}
 +
{{tp|p=32388676|t=2020. Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis.|pdf=|usr=008}}
 +
{{tp|p=32504963|t=2020. Cardiac arrest during emergency intubation in an elderly patient with confirmed coronavirus disease 2019.|pdf=|usr=008}}
 +
{{tp|p=32437935|t=2020. Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored.|pdf=|usr=008}}
 +
{{tp|p=32417379|t=2020. Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019.|pdf=|usr=008}}
 +
{{tp|p=32517963|t=2020. Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection.|pdf=|usr=008}}
 +
{{tp|p=32517962|t=2020. Takotsubo Cardiomyopathy in Males with Covid-19.|pdf=|usr=008}}
 +
{{tp|p=32310612|t=2020. Cardiac Manifestations Of Coronavirus (COVID-19)|pdf=|usr=008}}
 +
{{tp|p=32535752|t=2020. Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection.|pdf=|usr=008}}
 +
{{tp|p=32509415|t=2020. Heart Failure with Preserved Ejection Fraction in a Postpartum Patient with Superimposed Preeclampsia and COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32527136|t=2020. Large pulmonary cavity in COVID-19 cured patient case report.|pdf=|usr=008}}
 +
{{tp|p=32470634|t=2020. COVID-19 pandemic-Some cardiovascular considerations from the trench.|pdf=|usr=008}}
 +
{{tp|p=32425197|t=2020. Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City.|pdf=|usr=008}}
 +
{{tp|p=32489447|t=2020. Hemoptysis in COVID-19: Observation.|pdf=|usr=008}}
 +
{{tp|p=32474111|t=2020. Echocardiographic Findings in Covid-19 Pneumonia.|pdf=|usr=008}}
 +
{{tp|p=32457032|t=2020. Spontaneous pneumomediastinum in COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32423911|t=2020. Tension pneumothorax in a patient with COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32522523|t=2020. First documentation of persistent SARS-CoV-2 infection presenting with late acute severe myocarditis.|pdf=|usr=008}}
 +
{{tp|p=32516107|t=2020. Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report.|pdf=|usr=008}}
 +
{{tp|p=32420106|t=2020. ... atypical suspected myocarditis by SARS-CoV-2.|pdf=|usr=008}}
 +
{{tp|p=32423791|t=2020. COVID-19 (SARS-Cov-2) and the heart - An ominous association.|pdf=|usr=008}}
 +
{{tp|p=32531024|t=2020. Fulminant COVID-19-related myocarditis in an infant.|pdf=|usr=008}}
 +
{{tp|p=32525726|t=2020. Thoracoscopic Bullectomy for Persistent Air Leak in a 14-Year-Old Child with COVID-19 Bilateral Pulmonary Disease.|pdf=|usr=008}}
 +
{{tp|p=32415481|t=2020. 2019-Novel Coronavirus-Related Acute Cardiac Injury Cannot Be Ignored.|pdf=|usr=008}}
 +
{{tp|p=32528770|t=2020. A Review of Cardiac Complications in Coronavirus Disease 2019.|pdf=|usr=008}}
 +
{{tp|p=32528760|t=2020. Cardiac Manifestations of Coronavirus Disease 2019 (COVID-19): A Comprehensive Review.|pdf=|usr=008}}
 +
{{tp|p=32456695|t=2020. Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumonia.|pdf=|usr=008}}
 +
{{tp|p=32456648|t=2020. Two consecutive myocardial tissue insults for inpatients with COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32423461|t=2020. Cardiovascular phenotypes in ventilated patients with COVID-19 acute respiratory distress syndrome.|pdf=|usr=008}}
 +
{{tp|p=32430631|t=2020. Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient.|pdf=|usr=008}}
 +
{{ttp|p=32467792|t=2020. Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome as a Presentation of Coronavirus Disease 2019.|pdf=|usr=008}}
 +
{{tp|p=32533585|t=2020. COVID-19 and the heart: An update for clinicians.|pdf=|usr=008}}
 +
{{tp|p=32430514|t=2020. SARS-CoV-2 pulmonary infection revealed by subcutaneous emphysema and pneumomediastinum.|pdf=|usr=008}}
 +
 +
 +
{{tp|p=32405639|t=2020. At the heart of COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32523923|t=2020. Pericardial Fluid in a COVID-19 Patient: Is It Exudate or Transudate?|pdf=|usr=008}}
 +
{{tp|p=32524296|t=2020. Pneumomediastinum and spontaneous pneumothorax as an extrapulmonary complication of COVID-19 disease.|pdf=|usr=008}}
 +
{{tp|p=32523921|t=2020. Acute Pericarditis and Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge.|pdf=|usr=008}}
 +
{{tp|p=32523927|t=2020. COVID-19 Presenting as Acute Limb Ischaemia.|pdf=|usr=008}}
 +
{{tp|p=32523926|t=2020. Stress Cardiomyopathy in COVID-19 Disease.|pdf=|usr=008}}
 +
{{tp|p=32391885|t=2020. SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome.|pdf=|usr=008}}
 +
{{tp|p=32391877|t=2020. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019.|pdf=|usr=008}}
 +
{{tp|p=32412641|t=2020. Unusual presentation of acute coronary syndrome in a patient with SARS-CoV-2 infection.|pdf=|usr=008}}
 +
{{tp|p=32395765|t=2020. A case of Takotsubo cardiomyopathy with COVID 19.|pdf=|usr=008}}
 +
{{tp|p=32391912|t=2020. The role of cardiovascular imaging for myocardial injury in hospitalized COVID-19 patients.|pdf=|usr=008}}
 +
{{tp|p=32515698|t=2020. [Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic].|pdf=|usr=008}}
 +
{{tp|p=32515382|t=2020. Cardiovigilance in COVID 19.|pdf=|usr=008}}
 +
{{tp|p=32474800|t=2020. Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review.|pdf=|usr=008}}
 +
{{tp|p=32415992|t=2020. Emerging cardiological issues during the COVID-19 pandemic.|pdf=|usr=008}}
 +
{{tp|p=32399454|t=2020. Transient ST Segment Elevation in Two Patients with COVID-19 and a Normal Transthoracic Echocardiogram.|pdf=|usr=008}}
 +
{{tp|p=32399453|t=2020. Takotsubo Syndrome Associated with COVID-19.|pdf=|usr=008}}
 +
{{tp|p=32401577|t=2020. Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2c).|pdf=|usr=008}}
 +
{{tp|p=32475804|t=2020. Spontaneous pneumothorax and subcutaneous emphysema in COVID-19 patient: Case report.|pdf=|usr=008}}
 +
{{tp|p=32526224|t=2020. Cardiac injuries in coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
 +
{{tp|p=32352633|t=2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients |pdf=|usr=}}
 +
{{tp|p=32339025|t=2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best  Friend |pdf=|usr=}}
 +
 +
{{tp|p=32533323|t=2020. Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence?|pdf=|usr=008}}
 +
{{tp|p=32430627|t=2020. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches.|pdf=|usr=008}}

Aktuelle Version vom 12. September 2020, 17:22 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

 D further streaming-in related content is here
  • Air leak bullae, pneumothorax, -mediastinum...


32443345 2020. SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report.



to be sorted
32348058 2020. Les complications cardiaques de la maladie COVID-19 sont-elles associees a une mortalite plus elevee ?
32484975 2020. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.
32504747 2020. Cardiovascular complications in COVID-19: A systematic review and meta-analysis.
32395943 2020. Pericarditis aguda secundaria a COVID-19.
32433342 2020. Cardiovascular Manifestation and Treatment in COVID-19.
32453074 2020. Atrial Fibrillation in COVID-19: From epidemiological association to pharmacological implications.
32427645 2020. Pediatric Life-Threatening Coronavirus Disease 2019 With Myocarditis.
32433225 2020. Acute Inflammation and Elevated Cardiac Markers in a Two-Month-Old Infant with Severe Acute Respiratory Syndrome Coronavirus 2 Infection Presenting with Cardiac Symptoms.
32502128 2020. COVID-19-Associated Myocarditis in an Adolescent.
32512122 2020. Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.
32397558 2020. Impact of COVID-19 on the Cardiovascular System: A Review.
32393136 2020. COVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far?
32310612 2020. Cardiac Manifestations Of Coronavirus (COVID-19)
32360242 2020. COVID-19 Illness and Heart Failure: A Missing Link?
32310612 2020. Cardiac Manifestations Of Coronavirus (COVID-19)
32317203 ä. Cardiovascular complications in COVID-19
32303363 ä. ...impact sur le systeme cardiovasculaire...
32252591 2020. COVID-19 and the Heart
32331780 ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging
32318865 2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
32247212 2020. Cardiovascular disease and COVID-19
32354800 2020. Cardiovascular manifestations and treatment considerations in covid-19
32305329 2020. Cardiovascular and Logistic Issues Associated With COVID-19 Pandemic
32373465 ä. Syncope as the presenting symptom of COVID-19 infection
32315757 ä. Current data on the cardiovascular effects of the COVID-19
32355222 ä. A novel COVID-19 and its effects on cardiovascular disease
32360773 ä. May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?
32276773 ä. Commentary: What is the relationship between Covid-19 and cardiovascular disease?
32339565 ä. COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
32289321 ä. Cardiovascular molecular mechanisms of disease with COVID-19
C7151324 ä. The Heart in COVID19: Primary Target or Secondary Bystander?
32360242 2020. COVID-19 Illness and Heart Failure: A Missing Link?
32319272 2020. COVID-19 and cardiovascular disorder
32340429 2020. The role of natriuretic peptide estimation in severe COVID-19
32293449 2020. Prognostic value of NT-proBNP in patients with severe COVID-19
32139904 ä. COVID-19 and the cardiovascular system
32353374 ä. Towards precision management of cardiovascular patients with COVID-19 to reduce mortality
32372844 ä. COVID-19 y tratamiento guiado con tests de diagnostico bioquemicos y moleculares para reducir el dao cardiaco y la cardiotoxicidad
32355394 ä. COVID-19 y shock cardiogonico: diferentes formas de presentacion cardiovascular con alta mortalidad
32267110 2020. COVID-19 et maladies cardiovasculaires
32227794 2020. At the heart of the COVID-19 outbreak: early cardiac implications and mitigating strategies
32312365 2020. Research advances in cardiovascular system damage caused by SARS-CoV-2 in children
32243205 2020. The Variety of Cardiovascular Presentations of COVID-19

32354733 2020. SARS-CoV-2 pandemic and the cardiovascular system: What the non-cardiologist needs to know


32282502 ä. Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19)
32306491 2020. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review
32270559 2020. Cardiac and arrhythmic complications in patients with COVID-19
32219357 2020. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
32219363 2020. Potential Effects of Coronaviruses on the Cardiovascular System: A Review
32356626 ä. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
32118392 2020. Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations
32347088 2020. Effects of novel coronavirus therapeutic drugs on cardiovascular system
C7196397 ä. A review of cardiac manifestations and predictors of outcome in patients with COVID ? 19
32423554 2020. Coronavirus disease 2019 and the cardiovascular system: Impacts and implications
32451271 ä. Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications
32349897 2020. Cardiovascular Consequences and Considerations of Coronavirus Infection ? Perspectives for the Cardiothoracic Anesthesiologist and Intensivist During the Coronavirus Crisis
32297133 ä. Toward understanding the 2019 Coronavirus and its impact on the heart
32292848 2020. COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies
32292847 2020. The Heart in COVID-19: Primary Target or Secondary Bystander?
C7195441 ä. Prognostic Value of Right Ventricular Longitudinal Strain in Patients with COVID-19
32456948 ä. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19
32423664 ä. A close-up on COVID-19 and cardiovascular diseases
32368756 ä. HEART BRAKE-An unusual cardiac manifestation of Coronavirus disease 2019 (COVID-19)
32129583 2020. Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics
32409440 2020. The role of cardiac imaging in hospitalized COVID-19-positive patients.
32505331 2020. COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment?
32467423 2020. Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19.
32499236 2020. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?
32425184 2020. Sindrome Takotsubo in corso di polmonite da SARS-CoV-2: una possibile complicanza cardiovascolare.
32282026 2020. Call to action for the cardiovascular side of COVID-19.
32464652 2020. Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?
32464641 2020. Does epicardial fat contribute to COVID-19 myocardial inflammation?
32459851 2020. Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid the COVID-19 pandemic fight.
32469253 2020. The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) - a Systematic Echocardiographic Study.
32430971 2020. SARS-CoV2-related myocarditis-like syndroms: Shakespeare s question: What s in a name?
32462177 2020. Myocarditis detected after COVID-19 recovery.
32498096 2020. Intramural Hematoma as Unexpected Complication of COVID-19 Infection.
32464642 2020. Myocardial injury in severe COVID-19 infection.
32507570 2020. Acute myocarditis associated with COVID-19 infection.
32397816 2020. Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging.

32492436 2020. Covid-19 may be exacerbated by right-to-left interatrial shunt.


32427416 2020. COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.
32410761 2020. Cardiac Valves: Another "Disaster-Hit Area" of COVID-19 Patients?
32434385 2020. Cardiac Arrhythmias in COVID-19 Infection.
32405457 2020. Cardiac injury, Arrhythmia and Sudden death in a COVID-19 patient.
32449420 2020. Interpretation of arrhythmogenic effects of COVID-19 disease through ECG.
32494800 2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.
32490506 2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.
32473085 2020. SARS-COV-2 infection presenting as ST-elevationmyocardial infarction.
32473051 2020. Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.
32514586 2020. Myokarditis in der Ara von SARS-CoV-2: ein einzelnes Teilchen eines komplexen Puzzles?
32522617 2020. Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement.
32534109 2020. Involvement of Cardiovascular System As The Critical Point in Coronavirus Disease 2019 (COVID-19) Prognosis and Recovery.
32407771 2020. Acute Myocardial Injury at Hospital Admission is Associated with All-cause Mortality in COVID-19.
32449121 2020. Detailed hemodynamics of fulminant myocarditis caused by COVID-19.
32395425 2020. Spontaneous pneumomediastinum occurring in the SARS-COV-2 infection.
32388676 2020. Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis.
32504963 2020. Cardiac arrest during emergency intubation in an elderly patient with confirmed coronavirus disease 2019.
32437935 2020. Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored.
32417379 2020. Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019.
32517963 2020. Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection.
32517962 2020. Takotsubo Cardiomyopathy in Males with Covid-19.
32310612 2020. Cardiac Manifestations Of Coronavirus (COVID-19)
32535752 2020. Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection.
32509415 2020. Heart Failure with Preserved Ejection Fraction in a Postpartum Patient with Superimposed Preeclampsia and COVID-19.
32527136 2020. Large pulmonary cavity in COVID-19 cured patient case report.
32470634 2020. COVID-19 pandemic-Some cardiovascular considerations from the trench.
32425197 2020. Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City.
32489447 2020. Hemoptysis in COVID-19: Observation.
32474111 2020. Echocardiographic Findings in Covid-19 Pneumonia.
32457032 2020. Spontaneous pneumomediastinum in COVID-19.
32423911 2020. Tension pneumothorax in a patient with COVID-19.
32522523 2020. First documentation of persistent SARS-CoV-2 infection presenting with late acute severe myocarditis.
32516107 2020. Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report.
32420106 2020. ... atypical suspected myocarditis by SARS-CoV-2.
32423791 2020. COVID-19 (SARS-Cov-2) and the heart - An ominous association.
32531024 2020. Fulminant COVID-19-related myocarditis in an infant.
32525726 2020. Thoracoscopic Bullectomy for Persistent Air Leak in a 14-Year-Old Child with COVID-19 Bilateral Pulmonary Disease.
32415481 2020. 2019-Novel Coronavirus-Related Acute Cardiac Injury Cannot Be Ignored.
32528770 2020. A Review of Cardiac Complications in Coronavirus Disease 2019.
32528760 2020. Cardiac Manifestations of Coronavirus Disease 2019 (COVID-19): A Comprehensive Review.
32456695 2020. Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumonia.
32456648 2020. Two consecutive myocardial tissue insults for inpatients with COVID-19.
32423461 2020. Cardiovascular phenotypes in ventilated patients with COVID-19 acute respiratory distress syndrome.
32430631 2020. Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient.

32467792 2020. Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome as a Presentation of Coronavirus Disease 2019.


32533585 2020. COVID-19 and the heart: An update for clinicians.
32430514 2020. SARS-CoV-2 pulmonary infection revealed by subcutaneous emphysema and pneumomediastinum.



32405639 2020. At the heart of COVID-19.
32523923 2020. Pericardial Fluid in a COVID-19 Patient: Is It Exudate or Transudate?
32524296 2020. Pneumomediastinum and spontaneous pneumothorax as an extrapulmonary complication of COVID-19 disease.
32523921 2020. Acute Pericarditis and Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge.
32523927 2020. COVID-19 Presenting as Acute Limb Ischaemia.
32523926 2020. Stress Cardiomyopathy in COVID-19 Disease.
32391885 2020. SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome.
32391877 2020. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019.
32412641 2020. Unusual presentation of acute coronary syndrome in a patient with SARS-CoV-2 infection.
32395765 2020. A case of Takotsubo cardiomyopathy with COVID 19.
32391912 2020. The role of cardiovascular imaging for myocardial injury in hospitalized COVID-19 patients.
32515698 2020. [Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic].
32515382 2020. Cardiovigilance in COVID 19.
32474800 2020. Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review.
32415992 2020. Emerging cardiological issues during the COVID-19 pandemic.
32399454 2020. Transient ST Segment Elevation in Two Patients with COVID-19 and a Normal Transthoracic Echocardiogram.
32399453 2020. Takotsubo Syndrome Associated with COVID-19.
32401577 2020. Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2c).
32475804 2020. Spontaneous pneumothorax and subcutaneous emphysema in COVID-19 patient: Case report.
32526224 2020. Cardiac injuries in coronavirus disease 2019 (COVID-19).
32352633 2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients
32339025 2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend


32533323 2020. Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence?
32430627 2020. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches.

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis